| 20-03-02 | Dermira : Form 15-12B - Securities Registration Termination | PU |
| 20-02-20 | Dermira : SEC Filing - S-8 POS | PU |
| 20-02-20 | Dermira : SEC Filing - POS AM | PU |
| 20-02-20 | Dermira : Lilly Completes Acquisition of Dermira | PR |
| 20-02-11 | Dermira : Amended tender offer statement by Third Party | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Thompson
PSD | President | - | - |
Carly Loeb
COO | Chief Operating Officer | - | 2017-12-31 |
Gary Thompson
CMP | Compliance Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gordon Brooks
BRD | Director/Board Member | - | 2020-02-19 |
Philip Johnson
BRD | Director/Board Member | 61 | 2020-02-19 |
Michael Thompson
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20-02-19 | Issuer sale | Director | 68,377 | 0.1250% | ||
| 20-02-19 | Don | Chief Medical Officer; Director | 562,325 | 1.0281% | ||
| 20-02-19 | Issuer sale | Director | 54,585 | 0.0998% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.11% | - | - | 1.03B | |
| +2.17% | +3.71% | +73.32% | +132.05% | 56.21B | |
| +0.55% | +8.49% | +77.09% | +100.93% | 55.38B | |
| +0.93% | +4.11% | -12.64% | -12.98% | 23.75B | |
| +0.36% | +3.42% | +9.61% | +407.11% | 23.19B | |
| +3.64% | +8.34% | +39.81% | -5.88% | 18.14B | |
| +1.94% | +5.75% | +40.43% | -29.81% | 16.84B | |
| +1.49% | +17.24% | +174.91% | +344.55% | 15.86B | |
| -0.83% | +2.06% | +23.70% | +182.37% | 13.56B | |
| +7.20% | +13.33% | +42.13% | - | 12.97B | |
| Average | +1.74% | +6.94% | +52.04% | +139.79% | 26.21B | |
| Weighted average by Cap. | +1.63% | +6.60% | +56.62% | +132.21% |
Employees
-
